Dhanuka Laboratories is an API manufacturer based in India. It appears in 2 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with CDSCO (India) and MINSA (CR). Customs aggregates show $28.6M of exports covering 263 molecules to 16 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Gurgaon, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Cefixime | SFDA (Saudi Arabia) | 1 |
| Cefpodoxim Proxetil | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 1 | None |
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $6.2M | 9 |
| 2025 | Not reported | $28.6M | 16 |
| 2024 | Not reported | $29.8M | 17 |
| 2023 | Not reported | $22.7M | 14 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Dhanuka Laboratories comes back tiered against every other supplier able to file there.
Start for free